During the past decade, there has been an immense advancement in organ transplant technology. Organ preservation is required when an organ is removed from the body and is stored for transplant. Different methods are adopted for storing different organs. Different physical conditions need to be maintained while storing organs. The rising incidents of organ failures are boosting the organ preservatives market.
The growing number of patient who needs organ transplant is the primary market driver for organ preservative market. According to the United Network for Organ Sharing (UNOS), more than 400,000 renal transplantations have been performed since the first successful renal transplantation. Apart from this, growing diabetes and obese population worldwide is leading to organ failures. People suffering from high blood glucose are prone to renal failure. According to the World Health Organization (WHO), till 2015, 425 million people were diagnosed with diabetes worldwide. The early adoption of unhealthy habits like smoking and consumption of alcohol is also adding to the patient pool. The prevalence of desk-bound lifestyle and physical inactivity also leads to diseases which require a transplant in severe cases.
However, organ transplant and storage requires highly trained professionals and expertise. The devices required are expensive. These factors make the entire process very costly. Additionally, the risk involved in transplant and lack of organ donors are hindrances for the growth of the market. According to the Organ Procurement and Transplantation Network (OPTN), in 2017, more than 117,000 people were in a waiting list of national organ transplant and only 17,155 organs were transplanted in the year.
Nevertheless, the growing investment by government and private players in organ transplant techniques is pushing the market forward. Many NGOs and government are encouraging people for organ donation. Furthermore, many underdeveloped regions lack the facility of transplant creating an opportunity for market players to enter such areas.
The global organ preservation market is regionally segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
North America region is expected to dominate the market during the forecast period owing to their advanced healthcare technology and prevalence of diseases that lead to a transplant. According to the American Liver Foundation, around 8,000 liver transplant surgeries are performed in the United States every year. The large diabetic and obese population of the region also adds to the patient pool for the liver transplant. As per the American Diabetes Association, in 2015, 30.3 million Americans suffer from diabetes. Additionally, factors such as growing government initiatives and favorable reimbursement policies are fueling the growth of the market.
European region occupies the notable share of the organ preservative market. This is attributed to the advanced medical facilities available and an increasing number of patients in the region. Additionally, the fatty liver syndrome is prevalent in the region that leads to liver transplant; this further propels the growing market. Moreover, the favorable reimbursement policies and presence of key players in the region is driving the growth of the market.
Asia Pacific region is estimated to show the fastest growth during the forecast period. The growing expenditure in the healthcare sector and a huge geriatric population of the region is driving the growth of the region. The growing diabetic and obese people in the region are also adding to the patient pool. According to International Diabetes Federation (IDF), there were over 114 million cases of diabetes in China. Moreover, lack of facilities and expertise in the region provides an opportunity to capture the new markets of the region.
LAMEA region is expected to show slow growth. The area has huge potential and the patient pool is also large. Lack of medical facilities in the region is the cause of slow growth. However, the growing investment in healthcare, especially in the Middle East, is boosting the growth of the market in the region.
Teva Pharmaceutical Industries Ltd., BioLife Solutions, XVIVO Perfusion AB, Bristol-Myers Squibb Inc., Dr. Franz Kohler Chemie GmbH, Claris Lifesciences Limited, Lifeline Scientific, ToleroTech Inc., 21st Century Medicine, and CryoLife Inc. are the key players of organ preservative market.
In January 2017, Lifeblood Medical Inc. launched its first study comparing Lifor, also known as blood surrogate, with the industry's current gold standard for preservation of heart for transplantation.
Global Market Segmentation:
By Preservation Solutions
- Collins Solution
By Organ Type
By Preservation Technique
Hypothermic machine perfusion
Normothermic machine perfusion
- Organ banks
- Rest of Europe
- South Korea
- Rest of Asia pacific
- Saudi Africa
- South Africa
- Rest of LAMEA